It has also been shown to upregulate the expression of the early growth response gene-1 (Egr-1), a transcription factor that orchestrates the expression of multiple growth factors involved in wo Research Evidence Promotes VEGFR2-mediated angiogenesis in preclinical wound models (McGuire et al., 2025)Stimulates fibroblast migration and tendon outgrowth in ex vivo explant studies (Sikiric et al., 2021)Upregulates Egr-1 transcription factor, driving growth factor expression cascadeDemonstrates stability under physiological conditions due to high proline contentModulates nitric oxide signaling pathways in gastrointestinal and vascular tissue models Bottom line: BPC-157 is one of the most extensively studied synthetic peptides in preclinical regenerative research
Both drugs use tirzepatide a glucagon-like peptide-1, or GLP-1 as an active pharmaceutical ingredient
Gastrointestinal side effectssuch as nausea, vomiting, diarrhea, and constipationwere the most commonly reported, consistent with the GLP-1 drug class
Pen Peptide
Healing peptides are often used to support: tissue regeneration muscle repair ligament recovery joint healing inflammation regulation collagen production nerve repair Because peptides work with the bodys natural processes, they are commonly used as part of a regenerative medicine approach focused on improving recovery outcomes